drugset / Trial / NCT05286593

3D PET Myocardial Blood Flow and Rb82 Infusion Profiles

NCT05286593

Phase 4 Completed 98 enrolled Ochsner Health System Bracco Corporate · collab
RandomizedSequentialOpen-labelDiagnostic

Summary

The investigators seek to test bolus infusions (50ml/min) vs. slow infusions (20 ml/min) of Rb-82 on metrics of coronary blood flow assessed on a modern 3D PET/CT.

Timeline

Start
2021-12-28
Primary completion
2022-09-01
Completion
2022-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rubidium-82 Diagnostic / imaging agent